基本信息
浏览量:0
职业迁徙
个人简介
Research Interest
The role of spectroscopy in cervical cancer screening. Participating in a PO1 study with the Cancer Imaging department of BC Cancer Agency and the MD Anderson Cancer Institute in Houston, TX. Along with Dr. Matisic we are the Vancouver Pathologists who evaluate the cervical biopsies for this project. We have also evaluated the role of the molecular markers p16 and Ki67 in the objective classification of cervical dysplasia. Co-author of two peer reviewed articles from this project.
Molecular markers in invasive cervical cancer. Constructed a tissue microarray of invasive cervical carcinomas from patients diagnosed in Leipzig, Germany. Partly supervised a Post Graduate student (Dr. Hamid Masoudi) in evaluating various cell cycle proteins and proliferation markers in the prognosis of cervical carcinoma. First author of a peer reviewed paper that was submitted for publication (Am J Surg Pathol). Senior Author on another paper soon to be admitted. Senior author of a platform presentation, presented at the 2004 USCAP meeting in Vancouver by Dr. Masoudi.
The automation of cervical cancer screening. Was a member of the committee to evaluate the FocalPoint automatic screener in the Cervical Cancer Screening Program. A report detailing the findings has been issued. There was also a poster presentation highlighting our findings at the 2003 BC Cancer Agency Research day.
Anal cancer screening. Conducted a trial with the HIV centre for excellence at St. Pauls hospital, evaluating anal cancer screening by cytology. A total of 400 patients were enrolled. Two anal smears were submitted on each patient (one self sampled). The project is complete and the findings are being documented. At least two peer reviewed papers are expected from this study.
Fluorescent in situ hybridization (FISH) in urine cytology specimens. Did a preliminary assessment of the FISH assay (Vysis corp.) for urine specimens. Literature search showed promising results. Discussion with clinicians (Dr. Martin Gleave at VGH in particular) identified that the high cost of the assay and the relatively low cost of cystoscopies in BC will severely limit the use of this technology in BC.
Human papillomavirus (HPV) testing in cervical cancer screening
The role of spectroscopy in cervical cancer screening. Participating in a PO1 study with the Cancer Imaging department of BC Cancer Agency and the MD Anderson Cancer Institute in Houston, TX. Along with Dr. Matisic we are the Vancouver Pathologists who evaluate the cervical biopsies for this project. We have also evaluated the role of the molecular markers p16 and Ki67 in the objective classification of cervical dysplasia. Co-author of two peer reviewed articles from this project.
Molecular markers in invasive cervical cancer. Constructed a tissue microarray of invasive cervical carcinomas from patients diagnosed in Leipzig, Germany. Partly supervised a Post Graduate student (Dr. Hamid Masoudi) in evaluating various cell cycle proteins and proliferation markers in the prognosis of cervical carcinoma. First author of a peer reviewed paper that was submitted for publication (Am J Surg Pathol). Senior Author on another paper soon to be admitted. Senior author of a platform presentation, presented at the 2004 USCAP meeting in Vancouver by Dr. Masoudi.
The automation of cervical cancer screening. Was a member of the committee to evaluate the FocalPoint automatic screener in the Cervical Cancer Screening Program. A report detailing the findings has been issued. There was also a poster presentation highlighting our findings at the 2003 BC Cancer Agency Research day.
Anal cancer screening. Conducted a trial with the HIV centre for excellence at St. Pauls hospital, evaluating anal cancer screening by cytology. A total of 400 patients were enrolled. Two anal smears were submitted on each patient (one self sampled). The project is complete and the findings are being documented. At least two peer reviewed papers are expected from this study.
Fluorescent in situ hybridization (FISH) in urine cytology specimens. Did a preliminary assessment of the FISH assay (Vysis corp.) for urine specimens. Literature search showed promising results. Discussion with clinicians (Dr. Martin Gleave at VGH in particular) identified that the high cost of the assay and the relatively low cost of cystoscopies in BC will severely limit the use of this technology in BC.
Human papillomavirus (HPV) testing in cervical cancer screening
研究兴趣
论文共 80 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Nature medicineno. 4 (2023): 927-935
International journal of cancerno. 8 (2023): 1630-1639
medrxiv(2023)
引用0浏览0引用
0
0
Lancet regional health. Americas (2023): 100598-100598
Nivedha Raveinthiranathan,Jonathan Simkin,Robine Donken,Gina Ogilvie,Laurie Smith,Dirk Van Niekerk,Marette Lee,Ryan R. Woods
CURRENT ONCOLOGYno. 8 (2023): 7692-7705
引用0浏览0WOS引用
0
0
Social Science Research Network (2022)
CANCER RESEARCHno. 12 (2022)
引用0浏览0引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn